361 related articles for article (PubMed ID: 25565222)
1. Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis.
Rodríguez-Martín E; Picón C; Costa-Frossard L; Alenda R; Sainz de la Maza S; Roldán E; Espiño M; Villar LM; Álvarez-Cermeño JC
Clin Exp Immunol; 2015 May; 180(2):243-9. PubMed ID: 25565222
[TBL] [Abstract][Full Text] [Related]
2. Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation.
Hamann I; Dörr J; Glumm R; Chanvillard C; Janssen A; Millward JM; Paul F; Ransohoff RM; Infante-Duarte C
J Neuroimmunol; 2013 Jan; 254(1-2):165-9. PubMed ID: 22948090
[TBL] [Abstract][Full Text] [Related]
3. Human natural killer cell subsets and acute exercise: a brief review.
Timmons BW; Cieslak T
Exerc Immunol Rev; 2008; 14():8-23. PubMed ID: 19203081
[TBL] [Abstract][Full Text] [Related]
4. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
5. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
Huth TK; Brenu EW; Ramos S; Nguyen T; Broadley S; Staines D; Marshall-Gradisnik S
Scand J Immunol; 2016 Jan; 83(1):44-51. PubMed ID: 26381393
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell lytic activity and CD56(dim) and CD56(bright) cell distributions during and after intensive training.
Suzui M; Kawai T; Kimura H; Takeda K; Yagita H; Okumura K; Shek PN; Shephard RJ
J Appl Physiol (1985); 2004 Jun; 96(6):2167-73. PubMed ID: 14752119
[TBL] [Abstract][Full Text] [Related]
7. Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Gross CC; Schulte-Mecklenbeck A; Rünzi A; Kuhlmann T; Posevitz-Fejfár A; Schwab N; Schneider-Hohendorf T; Herich S; Held K; Konjević M; Hartwig M; Dornmair K; Hohlfeld R; Ziemssen T; Klotz L; Meuth SG; Wiendl H
Proc Natl Acad Sci U S A; 2016 May; 113(21):E2973-82. PubMed ID: 27162345
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Laroni A; Armentani E; Kerlero de Rosbo N; Ivaldi F; Marcenaro E; Sivori S; Gandhi R; Weiner HL; Moretta A; Mancardi GL; Uccelli A
J Autoimmun; 2016 Aug; 72():8-18. PubMed ID: 27157273
[TBL] [Abstract][Full Text] [Related]
9. Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis.
Sheridan JP; Zhang Y; Riester K; Tang MT; Efros L; Shi J; Harris J; Vexler V; Elkins JS
Mult Scler; 2011 Dec; 17(12):1441-8. PubMed ID: 21807759
[TBL] [Abstract][Full Text] [Related]
10. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases.
Lepennetier G; Hracsko Z; Unger M; Van Griensven M; Grummel V; Krumbholz M; Berthele A; Hemmer B; Kowarik MC
J Neuroinflammation; 2019 Nov; 16(1):219. PubMed ID: 31727097
[TBL] [Abstract][Full Text] [Related]
11. Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patients.
Johnson TA; Evans BL; Durafourt BA; Blain M; Lapierre Y; Bar-Or A; Antel JP
J Immunol; 2011 Jul; 187(1):570-9. PubMed ID: 21622858
[TBL] [Abstract][Full Text] [Related]
12. Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells.
Wendt K; Wilk E; Buyny S; Buer J; Schmidt RE; Jacobs R
J Leukoc Biol; 2006 Dec; 80(6):1529-41. PubMed ID: 16966385
[TBL] [Abstract][Full Text] [Related]
13. Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous system.
Oreja-Guevara C; Sindern E; Raulf-Heimsoth M; Malin JP
Acta Neurol Scand; 1998 Nov; 98(5):310-3. PubMed ID: 9858099
[TBL] [Abstract][Full Text] [Related]
14. Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection.
Naranbhai V; Chang CC; Durgiah R; Omarjee S; Lim A; Moosa MY; Elliot JH; Ndung'u T; Lewin SR; French MA; Carr WH
AIDS; 2014 Mar; 28(5):657-66. PubMed ID: 24451162
[TBL] [Abstract][Full Text] [Related]
15. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis.
Martínez-Rodríguez JE; López-Botet M; Munteis E; Rio J; Roquer J; Montalban X; Comabella M
Clin Immunol; 2011 Dec; 141(3):348-56. PubMed ID: 21992960
[TBL] [Abstract][Full Text] [Related]
17. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
18. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
[TBL] [Abstract][Full Text] [Related]
19. Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon-β and interferon-β combined with low-dose oral steroids.
Sanvito L; Tomita A; Chihara N; Okamoto T; Lin Y; Ogawa M; Gran B; Aranami T; Yamamura T
J Neuroimmunol; 2011 Jul; 236(1-2):111-7. PubMed ID: 21652010
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients.
Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Soofi M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):193-8. PubMed ID: 20404389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
